Abstract:Introduction. The patients with community-acquired pneumonia (CAP) and acute exacerbations of COPD (AECOPD) could have a higher risk of acute and severe respiratory illness than those without CAP in AECOPD. Consequently, early identification of pneumonia in AECOPD is quite important. Methods. 52 subjects with AECOPD + CAP and 93 subjects with AECOPD from two clinical centers were enrolled in this prospective observational study. The values of osteopontin (OPN), soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), C-reactive protein (CRP), procalcitonin (PCT), eosinophil (EOS) counts, and neutrophil (Neu) counts in blood on the first day of admission and clinical symptoms were compared in AECOPD and AECOPD + CAP. In addition, subgroup analyses of biomarker difference were conducted based on the current use of inhaled glucocorticoids (ICS) or systemic corticosteroids (SCS). Results. Patients with AECOPD + CAP had increased sputum volume, sputum purulence, diabetes mellitus, and longer hospital stays than AECOPD patients ( p < 0.05 ). A clinical logistic regression model showed among the common clinical symptoms, purulent sputum can independently predict pneumonia in AECOPD patients after adjusting for a history of diabetes. At day 1, AECOPD + CAP patients had higher values of Neu, CRP, PCT, and OPN, while serum sTREM-1 levels and EOS counts were similar in the two groups. CRP fared best at predicting AECOPD with CAP ( p < 0.05 for the test of difference), while OPN had similar accuracy with Neu, PCT, and purulent sputum ( p > 0.05 for the test of difference). Multivariate analysis, including clinical symptoms and biomarkers, suggested that CRP ≥15.8 mg/dL at day 1 was a only promising predictor of pneumonia in AECOPD. CRP and OPN were not affected by ICS or SCS. Conclusions. CRP ≥15.8 mg/dL is an ideal promising predictor of pneumonia in AECOPD, and its plasma level is not affected by ICS or SCS. The diagnostic performance of CRP is not significantly improved when combined with clinical symptoms or other markers (OPN, PCT, and Neu).

Changes of procalcitonin and C-reactive protein in acute phase of chronic obstructive pulmonary disease and its si nificance

Value of Procalcitonin in Guiding the Treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Clinical Significance of Serum Procalcitonin and Hs C-reactive Protein Levels on AECOPD

[The Changes and Clinical Implications of Serum Procalcitonin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease].

Dynamic changes and regression analysis of serum PCT and CRP in patients with AECOPD

Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Diagnostic Values Of C-Reactive Protein, Procalcitonin And Serum Amyloid A In Predicting Bacterial Infection In Patients With Acute Exacerbations Of Chronic Obstructive Pulmonary Disease

Significance of serum procalcitonin and C-reactive protein in patients with chronic obstructive pulmonary disease combined with pneumonia

The value of serum procalcitonin in treatment of acute exacerbations of chronic obstructive pulmonary disease

[Value of Serum Procalcitonin in Diagnosing Bacterial Lower Respiratory Tract Infections in People with Exacerbation of Chronic Obstructive Pulmonary Disease].

Changes of Metailoproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Interleukin-8 in Elderly Patients with Chronic Obstructive Pulmonary Disease and the Effects of Different Drugs

Clinical significance of CRP、WBC、N% in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease

C-reactive protein, white blood cells and serunm calcitonin level. and significance of Patients with bronchiectasis in diffenont ages

C-Reactive Protein Levels Predict Bacterial Exacerbation in Patients with Chronic Obstructive Pulmonary Disease

Clinical significance of C-reaction in acute exacerbation of chronic obstructive pulmonary disease protein

Determination of Biomarkers in Exhaled Breath Condensation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Clinical Implications

Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients

Changes of serum high-sensitivity C-reactive protein and prealbumin in the elderly COPD patients and their clinical application

Serum Inflammatory Factor and Cytokines in AECOPD

Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD

The correlation between serum procalcitonin and acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) score in acute exacerbation of chronic obstructive pulmonary disease